<code id='446B767D2A'></code><style id='446B767D2A'></style>
    • <acronym id='446B767D2A'></acronym>
      <center id='446B767D2A'><center id='446B767D2A'><tfoot id='446B767D2A'></tfoot></center><abbr id='446B767D2A'><dir id='446B767D2A'><tfoot id='446B767D2A'></tfoot><noframes id='446B767D2A'>

    • <optgroup id='446B767D2A'><strike id='446B767D2A'><sup id='446B767D2A'></sup></strike><code id='446B767D2A'></code></optgroup>
        1. <b id='446B767D2A'><label id='446B767D2A'><select id='446B767D2A'><dt id='446B767D2A'><span id='446B767D2A'></span></dt></select></label></b><u id='446B767D2A'></u>
          <i id='446B767D2A'><strike id='446B767D2A'><tt id='446B767D2A'><pre id='446B767D2A'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:36654
          Cigna Healthcare's logo on a phone
          Adobe

          CVS Health viewed Amy Bricker as a potential CEO. But she won’t be going to the health care conglomerate anytime soon.

          A federal appeals court has ruled Bricker, a former high-ranking executive at Cigna, cannot jump to CVS because it would violate her noncompete agreement that she signed while at Cigna. The appeals court’s decision backs up what a district court had previously ruled.

          advertisement

          The case is a prominent example of why the health care industry, and corporate America writ large, does not want noncompetes to go away. In April, the Federal Trade Commission approved a nationwide ban on most such agreements, which prevent workers from moving to other jobs, but companies and corporate lobbying groups have already sued to squash the ban.

          STAT+ Exclusive Story

          Already have an account? Log in

          STAT+

          This article is exclusive to STAT+ subscribers

          Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

          Already have an account? Log in

          Already have an account? Log in

          Monthly

          $39

          Totals $468 per year

          $39/month Get Started

          Totals $468 per year

          Starter

          $30

          for 3 months, then $39/month

          $30 for 3 months Get Started

          Then $39/month

          Annual

          $399

          Save 15%

          $399/year Get Started

          Save 15%

          11+ Users

          Custom

          Savings start at 25%!

          Request A Quote Request A Quote

          Savings start at 25%!

          2-10 Users

          $300

          Annually per user

          $300/year Get Started

          $300 Annually per user

          View All Plans

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          Wikipedia

          Alkermes shareholders re
          Alkermes shareholders re

          MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

          read more
          Hilary expected to bring catastrophic, life
          Hilary expected to bring catastrophic, life

          1:58WindblowspalmtreesattheMedanobeachbeforethearrivalofhurricaneHilaryatLosCabosresortinBajaCalifor

          read more
          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more

          ProMED sees offers of support, but its future remains unclear

          ProMEDmapScreengrabviaProMEDWithitsfutureindoubt,ProMED,thefinanciallystrappedinfectiousdiseasessurv